Daclizumab Biosimilar - Research Grade
Daclizumab Biosimilar - Research Grade
Product Details:ichorbio's daclizumab biosimilar is for Research Use Only (RUO)
Size:ichorbio's RUO daclizumab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of this biosimilar - please contact us for pricing.
Target:CD25
Isotype:IgG1
Other Names:Alpha subunit IL-2R, interleukin 2 receptor
Host:CHO cells
Species Reactivity:Human
Specificity:Detects human CD25.
Purification Method:This recombinant protein was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:Daclizumab biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Isotype Control: Use: ichorbio's daclizumab biosimilar is for research use only (RUO).| Concentration | 8.39mg/ml |
|---|---|
| Isotype | IgG1 |
| Host | CHO cells |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
| Applications | Functional Assays |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE |
| Formulation | Sterile, preservative-free, solution in PBS. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human CD25. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Daclizumab. |
| Species Reactivity | Human |
| Target | IL2RA |
| Shipping Conditions | Blue ice |
| background | RUO daclizumab biosimilar is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells. |
| Other names | Alpha subunit IL-2R, interleukin 2 receptor, CD25 |
| UniProt | P01589 |
| Buffer | ICH3002 |
| Sequence | https://www.imgt.org/mAb-DB/ |